CALCIUM ANTAGONISTS, A NEW CLASS OF ANTIHYPERTENSIVE AGENTS*
- 4 March 1988
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 2 (2) , 103-120
- https://doi.org/10.1111/j.1472-8206.1988.tb00626.x
Abstract
Summary—The mechanism of action of Ca++antagonists remains debatable. Not all voltage‐sensitive calcium channels have the same sensitivity to organic calcium blockers. Those in smooth muscle are clearly more sensitive than those in heart, and at least some of those in brain are not blocked at all. It is possible that in vascular smooth muscle, calcium antagonists act essentially on receptor‐operated channels.In any case, calcium antagonists are potent antihypertensive agents, but in clinical practice they have limitations. A second generation of dihydropyridines may provide a higher degree of therapeutic selectivity.Keywords
This publication has 41 references indexed in Scilit:
- ???Second Generation??? Dihydropyridine Calcium AntagonistsDrugs, 1987
- The expert committee of the World Health Organization on classification of calcium antagonists: The viewpoint of the raporteurThe American Journal of Cardiology, 1987
- Selective antagonism of humoral versus neural vasoconstrictor responses by nisoldipine.Hypertension, 1985
- Pharmacokinetics and absolute bioavailability of diltiazem in humansJournal of Molecular Medicine, 1984
- Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cellsNature, 1983
- Calcium Antagonists Clinical Use in the Treatment of Systemic HypertensionDrugs, 1983
- Calcium Antagonists Pharmacokinetic PropertiesDrugs, 1983
- Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectorisThe American Journal of Cardiology, 1982
- Role of cyclic nucleotides in heart metabolismCardiovascular Research, 1982
- Verapamil in the Management of Hypertensive PatientsAustralian and New Zealand Journal of Medicine, 1979